Literature DB >> 11744382

Endoglin expression in early development is associated with vasculogenesis and angiogenesis.

Leon Jonker1, Helen M Arthur.   

Abstract

Endoglin is an auxiliary receptor for the transforming growth factor-beta family of cytokines and is required for angiogenesis and heart development. Endoglin expression during mouse embryogenesis was analysed by monitoring beta-galactosidase expression from a lacZ reporter cassette inserted downstream of the endoglin promoter. Expression was first detected at 6.5 days post-coitum (dpc) in the amniotic fold and developing allantois. Between 7.5 and 8.5 dpc, endoglin was expressed in endothelial cells of the yolk sac, dorsal aorta and primitive heart tube, and from 9.5 to 13.5 dpc in endothelial cells throughout the developing vasculature. Interestingly, this pattern of endoglin expression is almost identical to that reported for Alk1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11744382     DOI: 10.1016/s0925-4773(01)00562-7

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  29 in total

Review 1.  ALK1 signaling in development and disease: new paradigms.

Authors:  Beth L Roman; Andrew P Hinck
Journal:  Cell Mol Life Sci       Date:  2017-09-04       Impact factor: 9.261

2.  Endothelial signaling and the molecular basis of arteriovenous malformation.

Authors:  Deepak Atri; Bruno Larrivée; Anne Eichmann; Michael Simons
Journal:  Cell Mol Life Sci       Date:  2013-09-28       Impact factor: 9.261

3.  Organ specific optical imaging of mitochondrial redox state in a rodent model of hereditary hemorrhagic telangiectasia-1.

Authors:  Zahra Ghanian; Sepideh Maleki; SunYoung Park; Christine M Sorenson; Nader Sheibani; Mahsa Ranji
Journal:  J Biophotonics       Date:  2013-06-06       Impact factor: 3.207

4.  A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.

Authors:  Takamune Takahashi; Keiko Takahashi; Patricia L St John; Paul A Fleming; Takuya Tomemori; Toshio Watanabe; Dale R Abrahamson; Christopher J Drake; Takuji Shirasawa; Thomas O Daniel
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 5.  ALK1 as an emerging target for antiangiogenic therapy of cancer.

Authors:  Sara I Cunha; Kristian Pietras
Journal:  Blood       Date:  2011-04-05       Impact factor: 22.113

Review 6.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

7.  BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation.

Authors:  Martin Moser; Olav Binder; Yaxu Wu; Julius Aitsebaomo; Rongqin Ren; Christoph Bode; Victoria L Bautch; Frank L Conlon; Cam Patterson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.

Authors:  Sung O Park; Young Jae Lee; Tsugio Seki; Kwon-Ho Hong; Naime Fliess; Zhigang Jiang; Alice Park; Xiaofang Wu; Vesa Kaartinen; Beth L Roman; S Paul Oh
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

9.  VE-cadherin is a critical endothelial regulator of TGF-beta signalling.

Authors:  Noemi Rudini; Angelina Felici; Costanza Giampietro; MariaGrazia Lampugnani; Monica Corada; Kendra Swirsding; Massimiliano Garrè; Stefan Liebner; Michelle Letarte; Peter ten Dijke; Elisabetta Dejana
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

10.  Kinetics of gene expression in murine cutaneous graft-versus-host disease.

Authors:  Philip B Sugerman; Sara B Faber; Lucy M Willis; Aleksandra Petrovic; George F Murphy; Jacques Pappo; David Silberstein; Marcel R M van den Brink
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.